Jiabei （Jay） Liu

Jay Liu's work experience begins in 2007 with an internship at Progenics Pharmaceuticals, Inc. From 2011 to 2016, they worked as a Graduate Research Assistant at the University at Buffalo (UB). In 2016, they joined Frontage Laboratories, Inc as a Clinical Scientist and Project Manager. In 2018, Jay held roles as the VP of Pharmaceutical Investment at StarLink Capital and as the Director of US BD and Licensing at Chongqing Pharscin Pharmaceutical. Jiabei （Jay） then joined Hua Medicine in 2019 as an Associate Director of Clinical Operations. Throughout their various roles, Jay has been involved in the development and evaluation of innovative drug products and devices, as well as establishing contacts with the international pharmaceutical community. Jiabei （Jay） has also been actively seeking late-stage oncology products for licensing in China.

Jiabei (Jay) Liu completed their education in Pharmacology and Toxicology with a Bachelor's and Master's degree from the University at Buffalo. Jiabei （Jay） pursued their undergraduate studies from 2006 to 2011, and then continued at the same institution to obtain their Doctor of Philosophy (Ph.D.) degree from 2011 to 2015.